J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depressive disorder. The disappointing result follows the Phase 3 failure of a Neumora Therapeutics drug that addresses the same central nervous system target. The post Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy appeared first on MedCity…
President-elect Donald Trump recently appointed former Paypal executive David Sacks as the White House’s first-ever czar for AI and cryptocurrency. Ryan Tarzy — CEO of Avandra Imaging, a federated network for de-identified imaging data — thinks this appointment could help accelerate the pace of innovation in the healthcare industry. The post Why One Startup CEO…
Ian Morrison died yesterday. 5 years ago in one of the early THCB Gang’s, we had a rash of late cancellations. So I talked to Ian solo about his journey, and his views about health care. I re-listened to it this morning and thought you might enjoy it
A new model of virtual care is emerging that promises to better democratize healthcare access for millions of Americans and revamp our care delivery system with a focus on value and efficiency. The post Democratizing Access to Care: The Rise of Virtual Centers of Excellence appeared first on MedCity News.
Weathering the storm will require a bold, multi-pronged approach encompassing legislative action and a data-informed approach that leverages AI technology to plan, recruit, and realign more efficient care models. The post A Perfect Storm is Brewing Within the U.S. Healthcare Workforce: Public Policy, Data, and AI Will Help Us Weather It appeared first on MedCity…
By MARC-DAVID MUNK In our palliative medicine clinic in the working suburbs of Boston, my colleagues and I tend to some of the sickest patients in the city. Through the window, I can see the afflicted pull up to our squat building in family sedans, wheelchair vans, and subsidized municipal ride cars. Few drive themselves:…
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
“El futuro está aquí”, anunciaba el correo electrónico. Hilda Jaffe, que entonces tenía 88 años, les estaba diciendo a sus hijos que pensaba vender la casa familiar de Verona, Nueva Jersey. Había decidido empezar una nueva vida, por su cuenta, en un apartamento de una habitación en Hell’s Kitchen, en Manhattan. Catorce años después, Jaffe,…
Mass firings at the FDA have decimated divisions tasked with releasing public records generated by the agency’s regulatory activities in sectors including tobacco, food, medical devices, and veterinary medicine. But as the dust settled on the layoff melee, a notable exception emerged among the agency’s staff charged with responding to Freedom of Information Act requests….
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…